Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections

Transfusion

Volumn 53, Issue 10 PART 2, 2013, Pages 2459-2466

  Vermeulen, Marion ^a,b,c,d   Coleman, Charl ^a,b,c,d   Mitchel, Josephine ^a,b,c,d   Reddy, Ravi ^a,b,c,d   Van Drimmelen, Harry ^a,b,c,d   Ficket, Tracy ^a,b,c,d   Lelie, Nico ^a,b,c,d  

^a SOUTH AFRICAN NATIONAL BLOOD SERVICE   (South Africa)

^b DDL DIAGNOSTIC LABORATORY   (Netherlands)

^c CREATIVE TESTING SOLUTIONS   (United States)

^d Lelie Research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ASYMPTOMATIC DISEASE; BLOOD; BLOOD DONOR; BLOOD SAMPLING; COMPARATIVE STUDY; DISEASE COURSE; EVALUATION STUDY; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MASS SCREENING; NUCLEIC ACID AMPLIFICATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; VIROLOGY; VIRUS LOAD; ARTICLE; METHODOLOGY; STATISTICS;

ASYMPTOMATIC DISEASES; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; DISEASE PROGRESSION; DNA, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84891694846     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12218     Document Type: Article

References (16)

1. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Transfusion 2009;49:289-300.
2. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, Van Drimmelen H, David B, Lelie N, De Micco P. Sensitivity of two hepatitis B virus, hepatitis C viris (HCV) and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV and p24/anti-HIV combination assays in seroconversion panels. Transfusion 2009;49: 301-10.
3. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C RNA and hepatitis B DNA. Transfusion 2007;47:1783-93.
4. Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009;49:1126-35.
5. Louisirirotchanakul S, Oota S, Khuponsarb K, Chalermchan W, Phikulsod S, Chongkolwatana V, Sakuldamrongpanish T, Kitpoka P, Chielsilp P, Tanprasert S, Tirawatnapong T, Wasi C; Working Group for NAT Study in Thai Blood Donations. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40.
6. Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Phikulsod S, Oota S, Lin M, Saldanha J, Kleinman SH. Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield. Transfusion 2011; 51:2012-22.
7. Allain JP, Belkhiri D, Vermeulen M, Crookes R, Cable R, Amiri A, Reddy R, Bird A, Candotti D. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009;49:1868-76.
8. Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyler M, Reddy R, Crookes R, Kramvis A. Hepatitis B virus transmission by blood transfusion during four years of individual donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion 2011;52:880-92.
9. Heermann KK, Gerlich WH, Chudy M, Schaefer S, Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference preparations. J Clin Microbiol 1999;37:68-73.
10. Vermeulen M, Coleman C, Mitchel J, Reddy R, Van Drimmelen H, Ficket T, Busch M, Lelie N. Comparison of HIV assays in window phase and elite controller samples: viral load distribution and implications for transmission risk. Transfusion. 2013;53:2384-98.
11. Weusten J, Vemeulen M, Van Drimmelen H, Lelie N. Refinement of a viral transmission risk model for blood donations in serconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 2011;51:203-15.
12. Tsoi WC, Lelie N, Lin CK. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription mediated amplification assay. Transfusion. 2013;53:2477-88.
13. Vermeulen M, Coleman C, Lelie N, Van Drimmelen H, Reddy R. Enhancement of HBV NAT yield after introduction of the Ultrio Plus assay. Vox Sang 2012;103 Suppl:161. (Abstract P-295).
14. Grabarczyk P, Van Drimmelen H, Kopacz A, Gdowska J, Liszewski G, Piotrowski D, Górska J, Kuśmierczyk J, Candotti D, Lȩtowska M, Lelie N, Brojer E. Head to head comparison of two transcription mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 in blood donors. Transfusion. 2013;53:2512-24.
15. Landers TA, Greenberg AB, Robinson WS, Structure of Hepatitis B. Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol 1977;23:368-76.
16. Chudy M, Hanschmann KM, Kress J, Nick S, Campos R, Wend U, Gerlich W, Nübling CM. First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA. J Clin Virol 2012;55: 303-9.